BackGenertec Universal Medical Group Company Limited Overview

Genertec Universal Medical Group Company Limited Accounts Payable

Track Genertec Universal Medical Group Company Limited's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00
↓ 100.00% YoYΔ $-2.54B vs prior year quarter

Peer trimmed avg / median

Loading

Genertec Universal Medical Group Company Limited Accounts Payable History

Loading

Genertec Universal Medical Group Company Limited vs. peers: Accounts Payable Comparison

Loading

Genertec Universal Medical Group Company Limited Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Genertec Universal Medical Group Company Limited (UMTAF) FAQ

Genertec Universal Medical Group Company Limited (UMTAF) currently reports a accounts payable of $0 as of June 2024. That compares with $2.5B in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Genertec Universal Medical Group Company Limited's accounts payable history and peer comparisons.

Genertec Universal Medical Group Company Limited's accounts payable decreased from $2.5B to $0 — a 100.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genertec Universal Medical Group Company Limited reported $0 in accounts payable as of June 2024. That compares with $2.5B in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genertec Universal Medical Group Company Limited, and consider following UMTAF for alerts when major investors trade the stock.